Normal view MARC view ISBD view

Crohn's disease or Crohn's diseases? [electronic resource]

By:

Arnott, I D R

Contributor(s):

Satsangi, J

Producer: 20030529Description: 460-1 p. digitalISSN:

0017-5749

Subject(s):

Online resources:

Available from publisher's website

In: Gut vol. 52

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Comment; Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 [Commemorative lecture of receiving Imamura Memorial Prize. Characterization of immunosuppressive macrophages induced in mice infected with Mycobacterium intracellulare].
by Tomioka, H
2 Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
by Tomioka, H
3 [Bronchial asthma and anti-allergic agents].
by Tomioka, H
4 [Attempts to elucidate the reasons why mycobacterial infections are generally intractable].
by Tomioka, H
5 [Bacteriology of mycobacteria: taxonomic and morphological characteristics].
by Tomioka, H
6 [Asthma].
by Tomioka, H
7 Purification and characterization of the tween-hydrolyzing esterase of Mycobacterium smegmatis.
by Tomioka, H
8 The localization of anti-heart antibodies to heart tissue in rats and rabbits with special reference to the induction of granuloma of Aschoff body type.
by Tomioka, H
9 [Attempts to elucidate reasons why mycobacterial infections are intractable, by using an experimental mouse infection model].
by Tomioka, H
10 [Bronchial asthma and prostaglandin related substances].
by Tomioka, H
11 [Allergy and its regulation].
by Tomioka, H
12 [Recent development in immunology of leprosy: roles of immunoregulatory cytokines in the establishment of immuno-unresponsiveness to M. leprae in leprosy patients].
by Tomioka, H
13 [Anti-IgE autoantibodies].
by Tomioka, H
14 [Physiopathology of asthma and the role of arachidonic acid metabolites].
by Tomioka, H
15 [Allergic diseases: progress in diagnosis and therapy. II. Approach to diagnosis and treatment. 2. New mode of application of anti-allergy preparations. 1) Anti-allergy preparations (chemical mediator release suppressing agents and antagonists)].
by Tomioka, H
16 [Progress in clinical microbiology of Mycobacterium avium complex and prospect on its future].
by Tomioka, H
17 [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections].
by Tomioka, H
18 Prospects for development of new antimycobacterial drugs.
by Tomioka, H
19 Suppressive factor against macrophage phagocytosis produced by cultured sarcoma-180 cells.
by Saito, H
20 Comparison of wheat germ agglutinin- and phorbol myristate acetate-mediated triggering for macrophage H2O2 release: susceptibilities to various macrophage inhibitors.
by Tomioka, H